Last 7 days
0.7%
Last 30 days
0.8%
Last 90 days
0.4%
Trailing 12 Months
7.6%
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 2.2B | 2.2B | 2.2B | 0 |
2022 | 2.2B | 2.2B | 2.2B | 2.2B |
2021 | 2.1B | 2.2B | 2.2B | 2.2B |
2020 | 2.0B | 2.0B | 2.0B | 2.1B |
2019 | 1.7B | 1.8B | 1.9B | 2.0B |
2018 | 1.5B | 1.6B | 1.6B | 1.7B |
2017 | 1.5B | 1.5B | 1.5B | 1.5B |
2016 | 1.3B | 1.4B | 1.4B | 1.4B |
2015 | 1.2B | 1.2B | 1.2B | 1.3B |
2014 | 1.2B | 1.2B | 1.2B | 1.2B |
2013 | 1.4B | 1.4B | 1.3B | 1.2B |
2012 | 1.5B | 1.5B | 1.5B | 1.4B |
2011 | 1.6B | 1.5B | 1.5B | 1.5B |
2010 | 1.5B | 1.6B | 1.6B | 1.6B |
2009 | 1.3B | 1.4B | 1.4B | 1.5B |
2008 | 820.3M | 942.7M | 1.1B | 1.2B |
2007 | 0 | 0 | 0 | 697.9M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Oct 20, 2023 | holton adam y | sold (taxes) | -47,204 | 92.74 | -509 | chief people officer |
Jul 25, 2023 | muscato nick | sold (taxes) | -15,473 | 91.02 | -170 | chief strategy officer |
Jun 26, 2023 | ginn scott g | acquired | - | - | 16,446 | evp, cfo & acting coo |
Jun 26, 2023 | ashworth richard m | acquired | - | - | 27,410 | president and ceo |
Jun 10, 2023 | bohnert denise m. | sold (taxes) | -42,870 | 91.8 | -467 | chief compliance officer |
May 03, 2023 | rideout jeffrey a | acquired | - | - | 1,941 | - |
May 03, 2023 | coye molly joel | acquired | - | - | 1,941 | - |
May 03, 2023 | kline teresa l. | acquired | - | - | 1,941 | - |
May 03, 2023 | klapstein julie d | acquired | - | - | 1,941 | - |
May 03, 2023 | perkins bruce d | acquired | - | - | 1,941 | - |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Dec 07, 2023 | Hudson Bay Capital Management LP | added | 1,952 | 29,611,200 | 31,094,000 | 0.12% |
Dec 06, 2023 | CITIGROUP INC | added | 0.74 | 476,212 | 16,915,000 | 0.01% |
Dec 06, 2023 | Raleigh Capital Management Inc. | unchanged | - | 59.00 | 2,802 | -% |
Nov 29, 2023 | Carmignac Gestion | added | 373 | 2,498,220 | 3,149,920 | 0.06% |
Nov 27, 2023 | BANQUE PICTET & CIE SA | unchanged | - | 18,404 | 877,026 | 0.01% |
Nov 24, 2023 | DEUTSCHE BANK AG\ | reduced | -95.52 | -3,206,690 | 153,643 | -% |
Nov 21, 2023 | COMERICA BANK | reduced | -22.49 | 1,274,950 | 1,275,950 | 0.01% |
Nov 16, 2023 | Financial Gravity Asset Management, Inc. | reduced | -98.9 | -47.00 | 113 | -% |
Nov 16, 2023 | Creative Planning | reduced | -2.08 | 56.00 | 325,098 | -% |
Nov 15, 2023 | Baker Avenue Asset Management, LP | added | 86.36 | 1,817 | 3,829 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Jul 06, 2023 | jpmorgan chase & co | 2.3% | 774,361 | SC 13G/A | |
May 18, 2023 | flynn james e | 5.51% | 1,794,000 | SC 13G | |
Feb 14, 2023 | ameriprise financial inc | 3.39% | 1,100,719 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 9.63% | 3,128,416 | SC 13G/A | |
Feb 06, 2023 | wellington management group llp | 8.63% | 2,802,831 | SC 13G/A | |
Jan 26, 2023 | blackrock inc. | 12.6% | 4,106,566 | SC 13G/A | |
Jan 20, 2023 | blackrock inc. | 12.6% | 4,106,566 | SC 13G | |
Jan 06, 2023 | jpmorgan chase & co | 5.4% | 1,763,327 | SC 13G | |
Feb 14, 2022 | ameriprise financial inc | 5.35% | 1,742,916 | SC 13G | |
Feb 09, 2022 | vanguard group inc | 9.69% | 3,158,777 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Oct 25, 2023 | 10-Q | Quarterly Report | |
Oct 24, 2023 | 8-K | Current Report | |
Oct 24, 2023 | 4 | Insider Trading | |
Sep 08, 2023 | 8-K | Current Report | |
Sep 05, 2023 | 3 | Insider Trading | |
Sep 01, 2023 | DEFA14A | DEFA14A | |
Sep 01, 2023 | 8-K | Current Report |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 508.7B | 360.0B | 2.46% | 0.72% | 23.46 | 1.41 | 14.24% | 11.62% |
CVS | 96.7B | 347.8B | 9.25% | -26.74% | 11.1 | 0.28 | 10.34% | 159.11% |
CI | 91.1B | 189.9B | -12.37% | -22.06% | 13.64 | 1.92 | 5.24% | 22.27% |
HCA | 69.2B | 63.2B | 11.16% | 6.57% | 12.11 | 1.1 | 5.62% | 6.32% |
CNC | 39.4B | 150.1B | 4.91% | -14.72% | 16.13 | 0.26 | 6.04% | 21.35% |
MID-CAP | ||||||||
DVA | 9.8B | 11.9B | 26.82% | 43.59% | 16.13 | 0.82 | 2.36% | -10.41% |
UHS | 9.6B | 14.0B | 6.07% | 6.08% | 14.25 | 0.69 | 6.03% | -8.61% |
CHE | 8.6B | 2.2B | -1.60% | 9.83% | 35.34 | 3.88 | 4.50% | -6.69% |
ACHC | 6.7B | 2.9B | -0.53% | -12.01% | -365.93 | 2.34 | 13.16% | -106.47% |
AMN | 2.6B | 4.1B | 13.56% | -40.93% | 9.25 | 0.63 | -25.26% | -41.25% |
SMALL-CAP | ||||||||
AMEH | 1.6B | 1.3B | 4.12% | 12.39% | 34.86 | 1.17 | 27.06% | -27.04% |
ADUS | 1.5B | 1.0B | 10.48% | -13.37% | 25.78 | 1.44 | 10.84% | 30.19% |
BKD | 1.0B | 3.0B | 22.30% | 77.33% | -8.11 | 0.34 | 6.98% | 58.07% |
BEAT | 35.8M | - | 8.80% | -76.75% | -2.47 | - | - | -27.68% |
AMS | 15.8M | 20.7M | 12.00% | -11.27% | 54.39 | 0.76 | 6.53% | -78.75% |
Income Statement (Quarterly) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Revenue | 0.6% | 556 | 553 | 556 | 562 | 558 | 558 | 545 | 559 | 554 | 564 | 537 | 551 | 544 | 485 | 492 | 501 | 495 | 493 | 467 | 434 | 417 |
Costs and Expenses | -0.2% | 514 | 515 | 514 | 516 | 519 | 510 | 497 | 511 | 497 | 491 | 477 | 495 | 486 | 458 | 448 | 459 | 448 | 448 | 423 | 398 | 377 |
EBITDA Margin | 5.5% | 0.04* | 0.04* | 0.09* | 0.09* | 0.10* | 0.11* | 0.13* | 0.14* | 0.15* | 0.16* | 0.13* | 0.12* | 0.11* | 0.10* | 0.10* | - | - | - | - | - | - |
Interest Expenses | 6.9% | 8.00 | 8.00 | 8.00 | 6.00 | 5.00 | 8.00 | 3.00 | 3.00 | 3.00 | 2.00 | 2.00 | 2.00 | 3.00 | 3.00 | 3.00 | 3.00 | 4.00 | 4.00 | 3.00 | 2.00 | 2.00 |
Income Taxes | -32.4% | 12.00 | 18.00 | 10.00 | 10.00 | 9.00 | 11.00 | 12.00 | 13.00 | 11.00 | 29.00 | 18.00 | 16.00 | -10.20 | 10.00 | 9.00 | 11.00 | 10.00 | 10.00 | 11.00 | 9.00 | 10.00 |
Earnings Before Taxes | 161.0% | 38.00 | -62.23 | 35.00 | 41.00 | 35.00 | 40.00 | 44.00 | 47.00 | 56.00 | 109 | 68.00 | 62.00 | 62.00 | 45.00 | 41.00 | 39.00 | 44.00 | 44.00 | 42.00 | 37.00 | 41.00 |
EBT Margin | 6.5% | 0.02* | 0.02* | 0.07* | 0.07* | 0.07* | 0.08* | 0.12* | 0.13* | 0.13* | 0.14* | 0.11* | 0.10* | 0.09* | 0.09* | 0.09* | - | - | - | - | - | - |
Net Income | 132.3% | 26.00 | -80.28 | 25.00 | 32.00 | 26.00 | 30.00 | 32.00 | 34.00 | 45.00 | 80.00 | 50.00 | 45.00 | 72.00 | 35.00 | 32.00 | 28.00 | 34.00 | 34.00 | 31.00 | 28.00 | 31.00 |
Net Income Margin | 13.8% | 0.00* | 0.00* | 0.05* | 0.05* | 0.05* | 0.06* | 0.09* | 0.09* | 0.10* | 0.11* | 0.10* | 0.09* | 0.08* | 0.07* | 0.06* | - | - | - | - | - | - |
Free Cashflow | -118.2% | -10.83 | 59.00 | 25.00 | 39.00 | -15.19 | 56.00 | 48.00 | 4.00 | 60.00 | 67.00 | 52.00 | 64.00 | 82.00 | 134 | 5.00 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Assets | 2.3% | 2,027 | 1,982 | 1,947 | 1,976 | 1,982 | 2,001 | 1,908 | 1,857 | 1,938 | 1,600 | 1,573 | 1,567 | 1,603 | 1,645 | 1,440 | 1,263 | 1,212 | 1,206 | 1,184 | 717 | 726 |
Current Assets | 9.5% | 467 | 427 | 406 | 389 | 389 | 395 | 392 | 357 | 433 | 391 | 380 | 362 | 411 | 450 | 468 | 351 | 300 | 276 | 272 | 224 | 233 |
Cash Equivalents | -18.1% | 78.00 | 95.00 | 49.00 | 41.00 | 31.00 | 49.00 | 71.00 | 46.00 | 128 | 93.00 | 78.00 | 83.00 | 115 | 180 | 178 | 96.00 | 21.00 | 14.00 | 11.00 | 20.00 | 14.00 |
Net PPE | 8.9% | 40.00 | 36.00 | 33.00 | 16.00 | 17.00 | 18.00 | 17.00 | 18.00 | 20.00 | 21.00 | 22.00 | 24.00 | 24.00 | 25.00 | 26.00 | 28.00 | 30.00 | 30.00 | 30.00 | 29.00 | 30.00 |
Goodwill | 0% | 1,245 | 1,245 | 1,245 | 1,287 | 1,285 | 1,290 | 9.00 | 1,196 | 1,188 | 937 | 933 | 933 | 931 | 937 | 721 | 659 | 660 | 665 | 650 | 330 | 324 |
Liabilities | 1.3% | 934 | 922 | 814 | 870 | 913 | 962 | 888 | 881 | 989 | 724 | 784 | 756 | 845 | 923 | 760 | 621 | 609 | 643 | 663 | 234 | 280 |
Current Liabilities | 1.2% | 468 | 462 | 353 | 356 | 367 | 427 | 380 | 374 | 454 | 449 | 456 | 456 | 437 | 442 | 316 | 327 | 315 | 313 | 297 | 222 | 219 |
Long Term Debt | -0.8% | 367 | 370 | 373 | 419 | 443 | 442 | 429 | 432 | 435 | 179 | 231 | 205 | 301 | 393 | 380 | 232 | 232 | 266 | 304 | 6.00 | 55.00 |
LT Debt, Current | - | - | - | - | - | - | - | - | - | - | - | - | 11.00 | - | - | - | 10.00 | - | - | - | 2.00 | - |
LT Debt, Non Current | - | - | - | - | - | - | - | - | - | - | - | - | 205 | - | - | - | 232 | - | - | - | 6.00 | - |
Shareholder's Equity | -2.0% | 1,040 | 1,061 | 1,133 | 1,052 | 1,070 | 1,039 | 1,021 | 976 | 949 | 876 | 790 | 811 | 758 | 722 | 680 | 642 | 603 | 563 | 521 | 483 | 445 |
Retained Earnings | 3.7% | 729 | 703 | 783 | 758 | 726 | 700 | 671 | 639 | 605 | 560 | 480 | 430 | 385 | 313 | 278 | 246 | 219 | 185 | 151 | 120 | 92.00 |
Additional Paid-In Capital | 1.1% | 777 | 769 | 759 | 755 | 751 | 743 | 737 | 728 | 721 | 714 | 707 | 698 | 690 | 666 | 656 | 645 | 635 | 623 | 614 | 604 | 593 |
Accumulated Depreciation | 3.7% | 94.00 | 91.00 | 105 | 101 | 102 | 100 | 99.00 | 97.00 | 100 | 99.00 | 98.00 | 95.00 | 102 | 101 | 98.00 | 96.00 | 101 | 99.00 | 97.00 | 95.00 | 93.00 |
Shares Outstanding | 0.1% | 33.00 | 33.00 | 33.00 | 33.00 | 32.00 | 33.00 | 33.00 | 33.00 | 33.00 | 33.00 | 33.00 | 33.00 | 33.00 | 32.00 | 32.00 | 32.00 | 32.00 | 32.00 | 32.00 | 32.00 | 32.00 |
Minority Interest | -0.7% | 54.00 | 54.00 | 54.00 | 55.00 | 54.00 | 53.00 | 54.00 | 45.00 | 44.00 | 2.00 | 1.00 | 2.00 | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Cashflow (Quarterly) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Cashflow From Operations | -116.2% | -9,843,000 | 60,759,000 | 25,961,000 | 40,883,000 | -13,630,000 | 57,409,000 | 48,621,000 | 5,166,000 | 61,767,000 | 67,958,000 | 54,002,000 | 65,912,000 | 83,083,000 | 133,922,000 | 6,035,000 | 75,220,000 | 47,455,000 | 59,266,000 | 20,059,000 | 64,033,000 | 68,480,000 |
Share Based Compensation | -20.5% | 7,243,000 | 9,108,000 | 3,273,000 | 570,000 | 3,495,000 | 5,148,000 | 7,347,000 | 5,940,000 | 4,397,000 | 6,156,000 | 7,307,000 | 6,972,000 | 7,124,000 | 6,725,000 | 5,909,000 | 6,589,000 | 6,298,000 | 5,538,000 | 6,615,000 | 5,247,000 | 4,842,000 |
Cashflow From Investing | 86.5% | -1,048,000 | -7,745,000 | 45,896,000 | -1,866,000 | -1,033,000 | -75,508,000 | -16,079,000 | -11,667,000 | -264,561,000 | -3,822,000 | -1,557,000 | -1,565,000 | -1,221,000 | -213,567,000 | -70,755,000 | -1,386,000 | -3,604,000 | -19,046,000 | -328,912,000 | -9,572,000 | -7,418,000 |
Cashflow From Financing | 42.9% | -6,254,000 | -10,953,000 | -56,890,000 | -16,344,000 | -2,641,000 | -4,046,000 | -7,402,000 | -75,938,000 | 238,356,000 | -49,834,000 | -57,458,000 | -96,443,000 | -146,736,000 | 82,160,000 | 146,042,000 | 1,899,000 | -36,996,000 | -36,872,000 | 299,178,000 | -48,242,000 | -72,956,000 |
Buy Backs | - | - | - | - | - | - | 17,351,000 | - | 14,999,000 | 10,805,000 | 1,188,000 | 72,886,000 | - | - | - | - | - | - | - | - | - | - |
CONSOLIDATED INCOME STATEMENT - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Income Statement [Abstract] | ||||
Net service revenue | $ 556,237 | $ 557,988 | $ 1,665,594 | $ 1,661,135 |
Cost of service, inclusive of depreciation | 311,628 | 322,227 | 924,093 | 943,258 |
General and administrative expenses: | ||||
Salaries and benefits | 129,083 | 125,550 | 380,926 | 376,788 |
Non-cash compensation | 6,612 | 3,495 | 18,968 | 15,990 |
Merger-related expenses | 4,980 | 0 | 25,151 | 0 |
Depreciation and amortization | 4,436 | 5,477 | 13,604 | 19,705 |
Investment impairment | 0 | 3,009 | 0 | 3,009 |
Other | 57,287 | 59,299 | 180,467 | 167,851 |
Total operating expenses | 514,026 | 519,057 | 1,543,209 | 1,526,601 |
Operating income | 42,211 | 38,931 | 122,385 | 134,534 |
Other income (expense): | ||||
Interest income | 1,304 | 59 | 2,452 | 108 |
Interest expense | (8,021) | (4,963) | (23,040) | (16,447) |
Equity in earnings (loss) from equity method investments | 1,252 | 302 | 9,366 | (442) |
Merger termination fee | 0 | 0 | (106,000) | 0 |
Miscellaneous, net | 1,201 | 491 | 5,262 | 1,155 |
Total other expense, net | (4,264) | (4,111) | (111,960) | (15,626) |
Income before income taxes | 37,947 | 34,820 | 10,425 | 118,908 |
Income tax expense | (12,331) | (9,417) | (40,381) | (32,755) |
Net income (loss) | 25,616 | 25,403 | (29,956) | 86,153 |
Net loss attributable to noncontrolling interests | 344 | 239 | 887 | 739 |
Net income (loss) attributable to Amedisys, Inc. | $ 25,960 | $ 25,642 | $ (29,069) | $ 86,892 |
Basic earnings per common share: | ||||
Net income (loss) attributable to Amedisys, Inc. common stockholders | $ 0.80 | $ 0.79 | $ (0.89) | $ 2.67 |
Weighted average shares outstanding, basic (shares) | 32,624 | 32,482 | 32,587 | 32,519 |
Diluted earnings per common share: | ||||
Net income (loss) attributable to Amedisys, Inc. common stockholders | $ 0.79 | $ 0.79 | $ (0.89) | $ 2.66 |
Weighted average shares outstanding, diluted (shares) | 32,831 | 32,616 | 32,587 | 32,680 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Sep. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 78,112 | $ 40,540 |
Restricted cash | 15,904 | 13,593 |
Patient accounts receivable | 319,580 | 296,785 |
Prepaid expenses | 20,534 | 11,628 |
Other current assets | 33,097 | 26,415 |
Total current assets | 467,227 | 388,961 |
Property and equipment, net of accumulated depreciation of $93,909 and $101,364 | 39,631 | 16,026 |
Operating lease right of use assets | 87,834 | 102,856 |
Goodwill | 1,244,679 | 1,287,399 |
Intangible assets, net of accumulated amortization of $12,838 and $14,604 | 103,634 | 101,167 |
Other assets | 84,412 | 79,836 |
Total assets | 2,027,417 | 1,976,245 |
Current liabilities: | ||
Accounts payable | 34,555 | 43,735 |
Payroll and employee benefits | 126,989 | 125,387 |
Accrued expenses | 139,100 | 137,390 |
Termination fee paid by UnitedHealth Group | 106,000 | 0 |
Current portion of long-term obligations | 35,364 | 15,496 |
Current portion of operating lease liabilities | 26,111 | 33,521 |
Total current liabilities | 468,119 | 355,529 |
Long-term obligations, less current portion | 366,853 | 419,420 |
Operating lease liabilities, less current portion | 61,878 | 69,504 |
Deferred income tax liabilities | 35,398 | 20,411 |
Other long-term obligations | 1,651 | 4,808 |
Total liabilities | 933,899 | 869,672 |
Commitments and Contingencies—Note 6 | ||
Equity: | ||
Preferred stock, $0.001 par value, 5,000,000 shares authorized; none issued or outstanding | 0 | 0 |
Common stock, $0.001 par value, 60,000,000 shares authorized; 38,065,853 and 37,891,186 shares issued; 32,633,599 and 32,511,465 shares outstanding | 38 | 38 |
Additional paid-in capital | 776,880 | 755,063 |
Treasury stock, at cost, 5,432,254 and 5,379,721 shares of common stock | (465,613) | (461,200) |
Retained earnings | 728,603 | 757,672 |
Total Amedisys, Inc. stockholders’ equity | 1,039,908 | 1,051,573 |
Noncontrolling interests | 53,610 | 55,000 |
Total equity | 1,093,518 | 1,106,573 |
Total liabilities and equity | $ 2,027,417 | $ 1,976,245 |
 CEO | Mr. Richard M. Ashworth |
---|---|
 WEBSITE | www.amedisys.com |
 EMPLOYEES | 20000 |